Milestone Pharmaceuticals, Inc. (MIST)
0.8999
-0.02
(-2.14%)
USD |
NASDAQ |
Sep 18, 11:14
Milestone Pharmaceuticals 30-Day Average Daily Volume : 1.739M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 1.739M |
| September 16, 2026 | 1.726M |
| September 15, 2026 | 1.718M |
| September 14, 2026 | 1.684M |
| September 11, 2026 | 1.634M |
| September 10, 2026 | 1.581M |
| September 09, 2026 | 1.618M |
| September 08, 2026 | 1.661M |
| September 04, 2026 | 1.642M |
| September 03, 2026 | 1.618M |
| September 02, 2026 | 1.584M |
| September 01, 2026 | 1.581M |
| August 31, 2026 | 1.562M |
| August 28, 2026 | 1.552M |
| August 27, 2026 | 1.576M |
| August 26, 2026 | 1.549M |
| August 25, 2026 | 1.550M |
| August 24, 2026 | 1.522M |
| August 21, 2026 | 1.487M |
| August 20, 2026 | 1.439M |
| August 19, 2026 | 1.393M |
| August 18, 2026 | 1.422M |
| August 17, 2026 | 1.420M |
| August 14, 2026 | 1.391M |
| August 13, 2026 | 1.353M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.300M |
| August 11, 2026 | 1.182M |
| August 10, 2026 | 1.208M |
| August 07, 2026 | 1.184M |
| August 06, 2026 | 1.246M |
| August 05, 2026 | 1.251M |
| August 04, 2026 | 1.279M |
| August 03, 2026 | 1.293M |
| July 31, 2026 | 1.307M |
| July 30, 2026 | 1.350M |
| July 29, 2026 | 1.329M |
| July 28, 2026 | 1.319M |
| July 27, 2026 | 1.256M |
| July 24, 2026 | 1.251M |
| July 23, 2026 | 1.252M |
| July 22, 2026 | 1.245M |
| July 21, 2026 | 1.272M |
| July 20, 2026 | 1.337M |
| July 17, 2026 | 1.343M |
| July 16, 2026 | 1.318M |
| July 15, 2026 | 1.333M |
| July 14, 2026 | 1.351M |
| July 13, 2026 | 1.340M |
| July 10, 2026 | 1.347M |
| July 09, 2026 | 1.406M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| InMed Pharmaceuticals, Inc. | 79444.47 |
| NervGen Pharma Corp. | 563680.6 |
| Clearmind Medicine, Inc. | 813853.0 |
| Lexaria Bioscience Corp. | 95136.30 |
| Target Group, Inc. (Canada) | 40492.27 |